熔点	144 ºC

危险品标志	T
危险类别码	R60;R61
安全说明书	S53;S45

来源	SDS样本
Sigma-Aldrich	浏览或下载
Cayman	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Determination of Coumarins in Cosmetics Application Note, 1128 (2016) [Anticoagulant therapy in practice].Gergely Hofgárt et al.Orvosi hetilap, 153(19), 732-736 (2012-05-09) Evaluation of the effect of genetic variations in GATA-4 on the phenprocoumon and acenocoumarol maintenance dose.Rianne M F van Schie et al.Pharmacogenomics, 13(16), 1917-1923 (2012-12-12) Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.Pierre Delanaye et al.BMC nephrology, 15, 145-145 (2014-09-06) An acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease.Alberto M Borobia et al.PloS one, 7(7), e41360-e41360 (2012-08-23) [Increased INR from concomitant use of acenocoumarol and capecitabine].Ben Tomlow et al.Nederlands tijdschrift voor geneeskunde, 156(26), A4793-A4793 (2012-07-05) Adrenal hemorrhage causing adrenal insufficiency in a patient with antiphospholipid syndrome: increased adrenal 18F-FDG uptake.Leo Boneschansker et al.The Journal of clinical endocrinology and metabolism, 97(9), 3014-3015 (2012-06-16) Creating a genotype-based dosing algorithm for acenocoumarol steady dose.Juan J Cerezo-Manchado et al.Thrombosis and haemostasis, 109(1), 146-153 (2012-12-01) Interaction between amorolfine and acenocoumarol.José A Morales-Molina et al.European journal of clinical pharmacology, 68(12), 1687-1688 (2012-06-01) Validation of the acenocoumarol EU-PACT algorithms: similar performance in the Rotterdam Study cohort as in the original study.Rianne M F van Schie et al.Pharmacogenomics, 13(11), 1239-1245 (2012-08-28) Genotype-guided dosing of vitamin K antagonists.Munir Pirmohamed et al.The New England journal of medicine, 370(18), 1764-1765 (2014-05-08) Phenprocoumon and acenocoumarol treatment in paediatric patients.Nienke Spoor et al.Thrombosis and haemostasis, 108(6), 1238-1241 (2012-09-28) Patients benefit from genetics-guided coumarin anticoagulant therapy.A H Maitland-van der Zee et al.Clinical pharmacology and therapeutics, 96(1), 15-17 (2014-06-20) Interaction between ciclopirox and acenocoumarol.José A Morales-Molina et al.European journal of clinical pharmacology, 69(3), 727-728 (2012-07-14) Chronic idiopathic urticaria successfully treated by anticoagulant drugs.Philip Spring et al.European journal of dermatology : EJD, 22(6), 788-790 (2012-11-28) [Ulcerated plaques of the aorta as a cause of ischaemic stroke].Justyna Rybicka et al.Kardiologia polska, 70(5), 524-526 (2012-05-25) Therapeutic dosing of acenocoumarol: proposal of a population specific pharmacogenetic dosing algorithm and its validation in north Indians.Saurabh Singh Rathore et al.PloS one, 7(5), e37844-e37844 (2012-05-26) A chiral separation strategy for acidic drugs in capillary electrochromatography using both chlorinated and nonchlorinated polysaccharide-based selectors.Dima Albals et al.Electrophoresis, 35(19), 2807-2818 (2014-07-02) Surgical management of severe spontaneous hemorrhage of the abdominal wall complicating acenocoumarol treatment.Orestis Ioannidis et al.Acta medica (Hradec Kralove), 55(1), 47-49 (2012-06-16) Non-vitamin K antagonist oral anticoagulants: an appeal for consensus on terminology.Gregory Y H Lip et al.Chest, 145(5), 1177-1178 (2014-05-07) [The bleeding into the emphysematosus bulla imitating lung tumor].Mirosław Trzciński et al.Pneumonologia i alergologia polska, 80(3), 275-279 (2012-05-09) Genotype-guided dosing of vitamin K antagonists.Stephen E Kimmel et al.The New England journal of medicine, 370(18), 1763-1764 (2014-05-03) A multiplex assay to detect variations in the CYP2C9, VKORC1, CYP4F2 and APOE genes involved in acenocoumarol metabolism.A M López-Parra et al.Clinical biochemistry, 46(1-2), 167-169 (2012-08-25) A rapid method for determination of 22 selected drugs in human urine by UHPLC/MS/MS for clinical application.Sylwia Magiera et al.Journal of AOAC International, 97(6), 1526-1537 (2015-01-30) D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.Gualtiero Palareti et al.Blood, 124(2), 196-203 (2014-06-01) Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial.Antonio J Carcas et al.Trials, 13, 239-239 (2012-12-15) [The potentiation of the anticoagulant effect of acenocoumarol by cefonicid].M Puente García et al.Revista clinica espanola, 199(9), 620-621 (1999-11-24) Genotype-guided dosing of vitamin K antagonists.Elizabeth A Koller et al.The New England journal of medicine, 370(18), 1761-1761 (2014-05-03) Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance dose.Rianne M F van Schie et al.Drug metabolism and drug interactions, 27(4), 229-234 (2012-10-26) CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences.Harumi Takahashi et al.Clinical pharmacology and therapeutics, 75(5), 376-380 (2004-04-30) [The efficacy and safety of acenocoumarol and warfarin therapy in patients with lower limb deep vein thrombosis].Sándor Iván Bernát et al.Orvosi hetilap, 153(20), 786-790 (2012-05-15) Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?Tiago Rafael Veloso et al.The Journal of infectious diseases, 211(1), 72-79 (2014-08-03) Cutaneous necrosis induced by acenocoumarol.M Valdivielso et al.Journal of the European Academy of Dermatology and Venereology : JEADV, 18(2), 211-215 (2004-03-11) Bioequivalence of acenocoumarol in chilean volunteers: an open, randomized, double-blind, single-dose, 2-period, and 2-sequence crossover study for 2 oral formulations.J Sasso et al.Arzneimittel-Forschung, 62(8), 395-399 (2012-07-10) The impact of the CYP2C9 and VKORC1 polymorphisms on acenocoumarol dose requirements in a Romanian population.Anca Dana Buzoianu et al.Blood cells, molecules & diseases, 50(3), 166-170 (2012-11-20) Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model.Liliane Gschwind et al.Basic & clinical pharmacology & toxicology, 113(4), 259-265 (2013-05-15) Atrial Fibrillation Update: A Textbook of Cardiology, 564-564 (2017) Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital.L Gschwind et al.European journal of clinical pharmacology, 69(3), 617-627 (2012-08-21) CYP2C9 and VKORC1 gene polymorphism is inessential for bleeding development under conditions of oral application of anticoagulant acenocoumarol in Russian patients at high risk of thromboembolic complications.D V Sychev et al.Bulletin of experimental biology and medicine, 153(6), 886-888 (2012-11-01) Genotype-guided dosing of vitamin K antagonists.Anke H Maitland-van der Zee et al.The New England journal of medicine, 370(18), 1765-1766 (2014-05-08) Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery.Marie Passemard et al.Retina (Philadelphia, Pa.), 32(9), 1868-1873 (2012-04-13) The effects of combined oral anticoagulant-aspirin therapy in patients undergoing tooth extractions: a prospective study.Branislav V Bajkin et al.Journal of the American Dental Association (1939), 143(7), 771-776 (2012-07-04)

备注